Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Buy
14,297
+1,303
+10% +$153K 0.09% 65
2026
Q1
$1.56M Buy
12,994
+185
+1% +$21.4K 0.09% 63
2025
Q4
$1.35M Buy
12,809
+9,406
+276% +$883K 0.08% 64
2025
Q3
$286K Buy
+3,403
New +$280K 0.03% 125
2025
Q2
Sell
-2,579
Closed -$232K 153
2025
Q1
$232K Buy
2,579
+172
+7% +$16.1K 0.03% 119
2024
Q4
$239K Sell
2,407
-1,513
-39% -$156K 0.03% 116
2024
Q3
$445K Sell
3,920
-7,866
-67% -$935K 0.11% 62
2024
Q2
$1.46M Sell
11,786
-968
-8% -$125K 0.08% 116
2024
Q1
$1.68M Sell
12,754
-13,754
-52% -$1.7M 0.13% 104
2023
Q4
$2.88M Sell
26,508
-42,084
-61% -$4.37M 0.16% 65
2023
Q3
$7.06M Sell
68,592
-13,143
-16% -$1.42M 0.38% 54
2023
Q2
$9.43M Sell
81,735
-433
-0.5% -$49.2K 0.5% 46
2023
Q1
$8.74M Buy
82,168
+6,969
+9% +$752K 0.48% 46
2022
Q4
$8.34M Buy
75,199
+4,787
+7% +$489K 0.49% 43
2022
Q3
$6.06M Sell
70,412
-45
-0.1% -$4.02K 0.41% 45
2022
Q2
$6.42M Buy
70,457
+57,601
+448% +$5.11M 0.43% 40
2022
Q1
$1.05M Buy
12,856
+3,129
+32% +$247K 0.07% 185
2021
Q4
$745K Sell
9,727
-2,454
-20% -$195K 0.05% 290
2021
Q3
$994K Hold
12,181
0.07% 219
2021
Q2
$947K Sell
12,181
-456
-4% -$33.9K 0.06% 244
2021
Q1
$930K Sell
12,637
-21,324
-63% -$1.57M 0.07% 216
2020
Q4
$2.65M Sell
33,961
-1,144
-3% -$87.5K 0.21% 73
2020
Q3
$2.78M Buy
35,105
+19,766
+129% +$1.55M 0.24% 66
2020
Q2
$1.13M Buy
+15,339
New +$1.15M 0.14% 72
2020
Q1
Sell
-24,569
Closed -$2.13M 330
2019
Q4
$2.13M Sell
24,569
-10,542
-30% -$866K 0.44% 36
2019
Q3
$2.82M Hold
35,111
0.58% 30
2019
Q2
$2.81M Sell
35,111
-1,268
-3% -$97.1K 0.57% 33
2019
Q1
$2.89M Buy
36,379
+15,576
+75% +$1.16M 0.49% 30
2018
Q4
$1.52M Buy
+20,803
New +$1.47M 0.39% 39

Other funds holding MRK

Symmetry Partners's MRK Position: Q2 2026 in Review

Symmetry Partners increased its Merck (MRK) stake by 10% in Q2 2026, buying an estimated $153K and bringing the position to 14,297 shares worth $1.84M. The position accounts for 0.09% of the portfolio, ranked #65.

Symmetry Partners first reported a position in MRK in Q4 2018 and has held it in 29 quarters since. The position peaked at $9.43M in Q2 2023. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Symmetry Partners held 14,297 shares of Merck worth $1.84M as of Q2 2026.
  • Symmetry Partners bought 1,303 Merck shares in Q2 2026, an estimated $153K.
  • Merck made up 0.09% of Symmetry Partners's portfolio in Q2 2026, its #65 holding.
  • Symmetry Partners first reported a position in Merck in Q4 2018 and has held it in 29 quarters since.
  • Symmetry Partners's Merck position peaked at $9.43M in Q2 2023.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Symmetry Partners's 13F filing for Q2 2026, filed 23 Jul 2026.